Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, describes a study which analyzed a subset of patients with multiple myeloma who relapsed post-CAR-T therapy, and subsequently received nivolumab. Whole-genome sequencing (WGS) and single-cell sequencing data were evaluated, and demonstrated that nivolumab may be used to restore T-cell fitness in some patients. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.